- Home
- XTNT vs VTGN Comparison
XTNT vs VTGN Comparison
Compare XTNT & VTGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XTNT
- VTGN
- Stock Information
- Founded
- XTNT N/A
- VTGN 1998
- Country
- XTNT United States
- VTGN United States
- Employees
- XTNT N/A
- VTGN N/A
- Industry
- XTNT Biotechnology: Biological Products (No Diagnostic Substances)
- VTGN Biotechnology: Pharmaceutical Preparations
- Sector
- XTNT Health Care
- VTGN Health Care
- Exchange
- XTNT Nasdaq
- VTGN Nasdaq
- Market Cap
- XTNT 60.9M
- VTGN 70.0M
- IPO Year
- XTNT N/A
- VTGN N/A
- Fundamental
- Price
- XTNT $0.61
- VTGN $2.13
- Analyst Decision
- XTNT
- VTGN
- Analyst Count
- XTNT 0
- VTGN 0
- Target Price
- XTNT N/A
- VTGN N/A
- AVG Volume (30 Days)
- XTNT 57.0K
- VTGN 163.8K
- Earning Date
- XTNT 08-07-2025
- VTGN 06-17-2025
- Dividend Yield
- XTNT N/A
- VTGN N/A
- EPS Growth
- XTNT N/A
- VTGN N/A
- EPS
- XTNT N/A
- VTGN N/A
- Revenue
- XTNT $122,298,000.00
- VTGN $486,000.00
- Revenue This Year
- XTNT $11.64
- VTGN N/A
- Revenue Next Year
- XTNT $7.59
- VTGN N/A
- P/E Ratio
- XTNT N/A
- VTGN N/A
- Revenue Growth
- XTNT 20.81
- VTGN N/A
- 52 Week Low
- XTNT $0.33
- VTGN $1.90
- 52 Week High
- XTNT $0.83
- VTGN $4.21
- Technical
- Relative Strength Index (RSI)
- XTNT 48.62
- VTGN 35.75
- Support Level
- XTNT $0.57
- VTGN $2.18
- Resistance Level
- XTNT $0.68
- VTGN $2.44
- Average True Range (ATR)
- XTNT 0.05
- VTGN 0.15
- MACD
- XTNT -0.02
- VTGN -0.03
- Stochastic Oscillator
- XTNT 30.44
- VTGN 1.89
About XTNT Xtant Medical Holdings Inc.
Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the US.
About VTGN VistaGen Therapeutics Inc.
Vistagen Therapeutics Inc is a biotechnology firm. The company is neuroscience-focused biopharmaceutical company dedicated to pursuing a pioneering approach to the development and commercialization of groundbreaking therapies for psychiatric and neurological disorders based on deep understanding of nose-to-brain neurocircuitry.